OR WAIT null SECS
November 18, 2020
The guidance was published in connection with a safety monitoring plan for COVID-19 vaccines.
The agency marked the annual European Antibiotic Awareness Day with the launch of a social media campaign highlighting the prudent use of antibiotics.
The event will be rescheduled for Oct. 19–21, 2021 at the Javits Center in New York City.
November 12, 2020
The first public announcement from the Biden-Harris transition team was to name members of a COVID-19 advisory board charged with initiating policies and actions to combat the fast-rising infection rate in the United States
Analysis from the CPhI Annual Report has revealed that the global contract services sector is benefitting from a switch toward COVID-19 manufacturing and clinical-stage contracts; however, mega-cap pharma innovation is slowing outsourcing.
November 11, 2020
Clarity from regulators, prior work on other vaccines, and closer collaboration with contract partners and suppliers have allowed Moderna and J&J to slash timeframes. Moderna may be on track to deliver initial doses to the highest risk patient populations before January 2021.
The program will consist of 10 University of Cambridge researchers and a group of PhD students who will work together to develop AI and machine learning technologies for clinical trials, personalized medicine, and biomedical discovery.
ISPE announced its 2020–2021 International Board of Directors during the virtual 2020 ISPE Annual Meeting & Expo on Nov. 6, 2020.
November 10, 2020
The vaccine will enter into a Phase III clinical trial in the United States and Mexico by the end of November, which could potentially support global authorization and approval of the vaccine.
November 04, 2020
With the presentation of research supporting the use of PTA technology, BioSkryb also launched its ResolveDNA platform for commercial use at ASHG 2020, held virtually on Oct. 27–30, 2020.